Chronic Kidney Disease as a Metabolic Syndrome with Malnutrition-Need for Strict Control of Risk Factors
Authors:
Open Access
- 1 January 2005
- journal article
- review article
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 44 (3) , 179-187
Abstract
Patients with chronic kidney disease (CKD) have an increased risk for death from cardiovascular disease (CVD). They have multiple metabolic abnormalities that may accelerate atherosclerosis, such as hypertension, insulin resistance, and dyslipidemia, along with other CKD-related risk factors. In addition, a considerable proportion of patients with advanced stages of CKD are malnourished, presenting “metabolic syndrome with malnutrition”. The presence of malnutrition/inflammation dramatically changes the apparent relationship between CVD death risk and some risk factors. For example, in stage 5 CKD patients on hemodialysis, a higher body mass index and a higher plasma cholesterol are predictors of better survival. To understand the paradoxic epidemiology, we should recognize risk factors for occurrence of CVD events and risk factors of fatality after an event. In this article, we review the unique situation of CKD, emphasizing the need of more strict control of both types of risk factors to improve survival of CKD patients.Keywords
This publication has 93 references indexed in Scilit:
- Gemfibrozil for secondary prevention of cardiovascular events in mild to moderate chronic renal insufficiencyKidney International, 2004
- Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patientsNephrology Dialysis Transplantation, 2004
- The association of antibodies against oxidized low-density lipoprotein with atherosclerosis in hemodialysis patientsKidney International, 2003
- Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal diseaseKidney International, 2002
- Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patientsKidney International, 2000
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?Kidney International, 1994
- Proteinuria as a Prognostic Factor during Long Term Hypertensive CareDrugs, 1988
- Selective Deficiency of Hepatic Triglyceride Lipase in Uremic PatientsNew England Journal of Medicine, 1977
- Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant PatientsNew England Journal of Medicine, 1977